Constellation Brands, Inc. Class A (STZ)

231.00
1.25 0.54
NYSE
Prev Close 229.75
Open 229.24
Day Low/High 228.68 / 232.90
52 Wk Low/High 104.28 / 240.76
Volume 1.84M
Exchange NYSE
Shares Outstanding 193.97B
Market Cap 45.40B
P/E Ratio 21.86
Div & Yield N.A. (N.A)
Cannabis Shorts: Is There Enough Liquidity?

Cannabis Shorts: Is There Enough Liquidity?

Before you short cannabis names, read this.

Cannabis Could Disrupt the Lucrative Market for Painkillers

Cannabis Could Disrupt the Lucrative Market for Painkillers

Painkiller manufacturers might see their profits hurt by medical cannabis in the near future.

Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis

Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis

The only other option is 'to fearfully wait' for the legal-weed industry to expand.

Despite Taking Some Weed, Constellation Brands Charts Are Still Bearish

Despite Taking Some Weed, Constellation Brands Charts Are Still Bearish

It is entirely possible that a business relationship with Canopy Growth will help Constellation Brands, but the charts currently suggest further risk for the beverage company.

Jim Cramer: Reefer Madness

Jim Cramer: Reefer Madness

Tilray's a disruptive company for many industries.

If You Must Trade Tilray, Use This Options Play: Market Recon

If You Must Trade Tilray, Use This Options Play: Market Recon

Covered calls may be the best bet -- or wait for a dip.

How to Play Tilray With Options

How to Play Tilray With Options

A so-called 'ratio-put spread' looks good here.

Play Tilray Using a 'Ratio-Put Spread'

Play Tilray Using a 'Ratio-Put Spread'

This options trade combines some upside with a chance to buy TLRY at a decent price.

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

The cannabis company has gained DEA approval to import a cannabinoid drug into the U.S.

Experts Are High on Cannabis Stocks' 2019 Prospects

Experts Are High on Cannabis Stocks' 2019 Prospects

Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.

Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest

Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest

A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.

Coke's Flirtation with Cannabis Reaffirms What We Already Know

Coke's Flirtation with Cannabis Reaffirms What We Already Know

The latest reports about Coke looking into cannabis confirms a broader industry trend.

Jim Cramer: Be Cautious Before You Invest in the Budding Cannabis Industry

Jim Cramer: Be Cautious Before You Invest in the Budding Cannabis Industry

You don't want your money to go up in smoke.

3 Big-Name Stocks to Consider Shorting

3 Big-Name Stocks to Consider Shorting

A brewer facing challenges, a banking giant and a retail behemoth are ripe for downside plays.

Cannabis for Traders, Cannabis for Investors: Market Recon

Cannabis for Traders, Cannabis for Investors: Market Recon

Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.

Mainstream Research Just Doesn't Get Canopy Growth

Mainstream Research Just Doesn't Get Canopy Growth

Moody's and Zacks aren't seeing the potential for CBD drinks or even THC drinks.

Canada's Hexo Pursues Additional JV Cannabis Deals After Molson

Canada's Hexo Pursues Additional JV Cannabis Deals After Molson

Hexo is pursuing joint ventures in cosmetics, health care, candy, edibles, and vape companies.

Advisors, Analysts Brush Off Nike Controversy, Say Selloff Is Short-Lived

Advisors, Analysts Brush Off Nike Controversy, Say Selloff Is Short-Lived

Analysts and advisors stand by Nike as NFL.

Tilray Feeds Deal-Making Speculation on Analyst Call

Tilray Feeds Deal-Making Speculation on Analyst Call

Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.

Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend

Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend

Seasonality hasn't mattered in a number or years so why should light volume new highs be an issue?

Jim Cramer: The Great Ones Disrupt Their Own

Jim Cramer: The Great Ones Disrupt Their Own

Two companies, PepsiCo and Constellation Brands, are disrupting their own businesses and getting no credit whatsoever for doing so.

'Fear of Missing Out': Analysts Question Constellation's Big Canopy Play

'Fear of Missing Out': Analysts Question Constellation's Big Canopy Play

Even bullish analysts are cautious on Constellation's big cannabis bet.

Here's How to Play Canopy Growth If You Missed Wednesday's Big Pop-Up

Here's How to Play Canopy Growth If You Missed Wednesday's Big Pop-Up

Odds are good that you'll make at least 8% in 37 days using this put play.

How to Play Canopy Growth Using Put Options

How to Play Canopy Growth Using Put Options

Odds are good that you'll make at least 8% in 37 days using this play.

Constellation Brands Invests $4 Billion in Canopy Growth: Is Takeover Imminent?

Constellation Brands Invests $4 Billion in Canopy Growth: Is Takeover Imminent?

Constellation Brand's bigger stake in Canopy has analysts mulling the prospects of a takeover.

Canopy Growth Soars Without Any Advance Clues - Exercise Patience

Canopy Growth Soars Without Any Advance Clues - Exercise Patience

With the price of CGC up around 8% this morning a fresh look at the charts is in order.

Canopy Growth Is a Positive Spot in this Sea of Red

Canopy Growth Is a Positive Spot in this Sea of Red

CGC and STZ should both remain 'go to' plays on the marijuana industry.

From Cannabis to China: Beer Companies Chase New Growth Opportunities

From Cannabis to China: Beer Companies Chase New Growth Opportunities

Beer companies are going to greater lengths to grow.